Evidence map›Paper›PMID 42588417›Full record

ArticleMolecules (Basel, Switzerland)2026

LogPpred: An AI-Based Predictive Model for Accurate Estimation of Molecular LogP.

Lisa Piazza, Lara Sortino, Alessio Costa, Clarissa Poles, Federico Fornaseri, Stefano Sainas, Marta Giorgis, Giulio Poli, Marco Macchia, Marco L Lolli and 2 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lisa PiazzaDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.ORCID 0009-0007-5062-4590
Lara SortinoDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.ORCID 0009-0007-4603-9743
Alessio CostaDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.ORCID 0009-0002-0894-2062
Clarissa PolesGenomics and Experimental Medicine Program, Scuola Superiore Meridionale (SSM, School of Advanced Studies), Via Mezzocannone 4, 80078 Napoli, Italy.
Federico FornaseriDepartment of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy.ORCID 0009-0000-0132-0274
Stefano SainasDepartment of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy.ORCID 0000-0001-5010-8536
Marta GiorgisDepartment of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy.ORCID 0000-0002-3282-1220
Giulio PoliDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Marco MacchiaDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.
Marco L LolliDepartment of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy.
Tiziano TuccinardiDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-6205-4069
Miriana Di StefanoDepartment of Pharmacy, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-6727-5816

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipophilicity, commonly described by the n-octanol/water partition coefficient (LogP), is a key physicochemical property influencing the pharmacokinetic behavior of small molecules. Reliable LogP estimation during the early stages of drug discovery is essential to support molecular design and prioritize compounds with favorable ADMET properties. In this work, we report the development of LogPpred, an AI-based predictor of molecular lipophilicity. Starting from a curated dataset of 13,536 molecules with experimentally determined LogP values, multiple machine learning algorithms and molecular representations were systematically evaluated. The best-performing model, based on Gaussian Process Regression and RDKit molecular descriptors, achieved a mean absolute error (MAE) of 0.34 on the independent internal test set. External validation on a fully independent OECD-derived dataset yielded an MAE of 0.84, demonstrating good generalization capability across diverse chemical space. Furthermore, experimental LogP determination of an additional set of independently selected compounds confirmed the predictive reliability of the model, yielding an MAE of 0.66. Comparative analyses showed that LogPpred outperformed several widely used LogP prediction tools. Applicability domain analysis further supported the reliability of the model, with MAE values improving to 0.28 and 0.62 for in-domain compounds in the internal and external validation sets, respectively. Overall, LogPpred represents a robust, accurate, and transparent tool for the early assessment of molecular lipophilicity in medicinal chemistry and drug discovery.

Indexed as

1-OctanolArtificial IntelligenceWaterAlgorithmsDrug DiscoveryHydrophobic and Hydrophilic InteractionsMachine LearningPrediction AlgorithmsPredictive Learning ModelsReproducibility of Results1-OctanolWaterADMETapplicability domaindrug discoverylipophilicityLogP predictionmachine learningmedicinal chemistry

Identifiers

PMID42588417
PMCPMC13468394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.